Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 12-2015 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,376 | N/A | 14,454 | 23,649 | 33,748 |
| Marketable Securities | 1,852 | N/A | 6,925 | 7,024 | 2,108 |
| Receivables | 2,384 | N/A | 5,479 | 2,361 | 484 |
| Other current assets | 62 | 0 | 62 | 62 | 62 |
| TOTAL | $20,674 | $N/A | $26,920 | $33,096 | $36,402 |
| Non-Current Assets | |||||
| PPE Net | 4,047 | N/A | 3,775 | 4,076 | 4,366 |
| TOTAL | $4,047 | $N/A | $3,775 | $4,076 | $4,366 |
| Total Assets | $24,721 | $N/A | $30,695 | $37,172 | $40,768 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,920 | 0 | 1,349 | 1,315 | 2,051 |
| TOTAL | $1,920 | $N/A | $1,349 | $1,315 | $2,051 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 97 | 0 | 110 | 327 | 465 |
| TOTAL | $97 | $N/A | $110 | $327 | $465 |
| Total Liabilities | $2,017 | $N/A | $1,459 | $1,642 | $2,516 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 143 | N/A | N/A | 143 | N/A |
| Common Shares | 727 | N/A | 727 | 727 | 689 |
| Retained earnings | -62,625 | N/A | -56,093 | -49,799 | -46,297 |
| Other shareholders' equity | -378 | 0 | -378 | -378 | 0 |
| TOTAL | $22,704 | $N/A | $29,236 | $35,530 | $38,252 |
| Total Liabilities And Equity | $24,721 | $0 | $30,695 | $37,172 | $40,768 |